Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022

Author's Avatar
Feb 18, 2022

Akili+Interactive (“Akili” or the “Company”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that Chief Financial Officer, Santosh Shanbhag, and Vice President of Marketing, Blake Schiller, will each participate in panel discussions at the fifth annual DTx West event, a conference designed to bring together leaders within digital therapeutics (DTx) to accelerate knowledge and the advancement of DTx into mainstream healthcare.